Skip to main content
SpringerLink
Log in

Cetuximab und FOLFOX-4 beim metastasierten kolorektalen Karzinom

Cetuximab and FOLFOX-4 in metastasized colorectal cancer

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Tejpar S, Stintzing S, Ciardiello F et al (2017) Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: Retrospective analyses of the CRYSTAL and FIRE-3 trials. Jama Oncol 3(2):194. https://doi.org/10.1001/jamaoncol.2016.3797

    Article  Google Scholar 

  2. Van Cutsem E, Lenz HJ, Köhne CH et al (2015) Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol 33:692–700

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Köln (AöR), Kerpener Straße 62, 50937, Köln, Deutschland

    Fabian Kütting

  2. Klinik und Poliklinik für Allgemein‑, Viszeral- und Tumorchirurgie, Universitätsklinikum Köln (AöR), Köln, Deutschland

    Hakan Alakus &  Christiane Bruns

Authors
  1. Fabian Kütting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hakan Alakus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christiane Bruns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabian Kütting.

Ethics declarations

Interessenkonflikt

F. Kütting, H. Alakus und C. Bruns geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kütting, F., Alakus, H. & Bruns, C. Cetuximab und FOLFOX-4 beim metastasierten kolorektalen Karzinom. Onkologe 24, 1034–1036 (2018). https://doi.org/10.1007/s00761-018-0475-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-018-0475-z

Search

Navigation